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Background: MicroRNAs (miRNAs) are a class of important gene regulators. The number of identified miRNAs has
been increasing dramatically in recent years. An emerging major challenge is the interpretation of the genome-
scale miRNA datasets, including those derived from microarray and deep-sequencing. It is interesting and
important to know the common rules or patterns behind a list of miRNAs, (i.e. the deregulated miRNAs resulted
from an experiment of miRNA microarray or deep-sequencing).
Results: For the above purpose, this study presents a method and develops a tool (TAM) for annotations of
meaningful human miRNAs categories. We first integrated miRNAs into various meaningful categories according to
prior knowledge, such as miRNA family, miRNA cluster, miRNA function, miRNA associated diseases, and tissue
specificity. Using TAM, given lists of miRNAs can be rapidly annotated and summarized according to the integrated
miRNA categorical data. Moreover, given a list of miRNAs, TAM can be used to predict novel related miRNAs.
Finally, we confirmed the usefulness and reliability of TAM by applying it to deregulated miRNAs in acute
myocardial infarction (AMI) from two independent experiments.
Conclusion: TAM can efficiently identify meaningful categories for given miRNAs. In addition, TAM can be used to
identify novel miRNA biomarkers. TAM tool, source codes, and miRNA category data are freely available at http://
cmbi.bjmu.edu.cn/tam.
Background
MicroRNAs (miRNAs) are one class of newly identified
important cellular components [1]. At the posttranscrip-
tional level, miRNAs normally act as negative gene regu-
lators by binding to the 3’UTR of target mRNAs
through base pairing, which results in the cleavage of
target mRNAs or translation inhibition [1]. Increasing
evidences suggest that miRNAs play crucial roles in
nearly all important biological processes, including cell
g r o w t h ,p r o l i f e r a t i o n ,d i f f e r e n t i a t i o n ,d e v e l o p m e n t ,a n d
apoptosis [2], and that miRNA dysfunctions are asso-
ciated with various diseases [3]. Since their discovery,
the number of identified miRNAs has been increasing
dramatically and various high-throughput techniques
related to miRNAs are continuously being developed.
Microarrays, for example, generate experimental data at
rates that exceed knowledge growth. To mine meaning-
ful information of miRNAs, a number of tools and data-
bases have been presented [4-12]. Among these
resources, the tools for searching for the gene sets (i.e.
KEGG pathways and Gene Ontology) that may be
affected by one or multiple miRNAs represent some of
the most important tools in miRNA bioinformatics
[6,10,11]. A common point of these methods is that
they obtain the meaningful gene sets by enrichment
analysis of the in-silico predicted miRNA targets. The
first limitation of these methods is the high false posi-
tives and high false negatives of the predicted miRNA
targets [13]. The second limitation of these methods is
that they perform analysis based on target genes and
only focus on significantly enriched gene sets and there-
fore may fail to find some functions or biological pro-
cesses associated with the inputted miRNAs. For
example, miR-18a is known to be related to apoptosis
* Correspondence: cuiqinghua@hsc.pku.edu.cn
1Department of Biomedical Informatics, Peking University Health Science
Center, Beijing, 100191, China
Full list of author information is available at the end of the article
Lu et al. BMC Bioinformatics 2010, 11:419
http://www.biomedcentral.com/1471-2105/11/419
© 2010 Lu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
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tosis” for miR-18a. Finally, it seems difficult for those
methods to find novel miRNAs that are related to the
inputted miRNAs. Therefore, for a list of miRNAs, for
example the upregulated and/or downregulated miRNAs
from a miRNA microarray experiment, novel methods
are needed to find the patterns behind these miRNAs.
Most of the current tools for miRNA functional anno-
tation are based on predicted miRNA targets, mainly,
because of the lack of miRNA knowledge resources.
However, functional resources for protein-coding genes
are easily available. Therefore, for protein-coding genes,
a large number of programs for the annotation of lists
of genes have been developed [15] because various gene
resources such as the Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathway http://www.genome.jp/kegg/
and the Online Mendelian Inheritance in Man (OMIM)
compendium http://www.ncbi.nlm.nih.gov/omim/ are
available for protein-coding genes. Developing miRNA
annotation tools should become more feasible as mean-
ingful miRNA resources are collected. In this study,
TAM, a web-accessible program for this purpose is pre-
sented. In TAM, miRNAs are integrated into different
categories according to the miRNA family, genome loca-
tions, functions, associated diseases, and tissue specifi-
city. TAM then evaluates the statistical significance (i.e.,
overrepresentation or underrepresentation) of each
miRNA category among lists of miRNAs using the
hypergeometric test. TAM is also able to search for
novel miRNAs related to a given list of miRNAs. Finally,
we applied TAM to the upregulated miRNAs and down-
regulated miRNAs in acute myocardial infarction (AMI).
As expected, different meaningful miRNA categories
have been identified for upregulated and downregulated
miRNAs, respectively. This suggested that TAM could
be an efficient method and tool for the annotation of
meaningful miRNA categories for a list of miRNAs.
TAM represents an alternative tool for the processing of
outputs of high throughput miRNA experiments.
Results and Discussion
miRNA categories
In total, we collected 257 miRNA categories according
to various classification schemes, such as miRNA family,
miRNA cluster, miRNA function, miRNA associated dis-
ease, and miRNA tissue specificity (see Materials and
Methods). miRNAs that have common characters in any
classification scheme will be integrated into one cate-
gory. Figure 1 shows the detailed flowchart for the
miRNA category integration procedure (Figure 1).
Among the 257 miRNA categories, 58 belongs to
miRNA family category (Family), 72 belongs to miRNA
cluster category (Cluster), 24 belongs to miRNA func-
tion category (Function), 97 belongs to human miRNA
associated disease category (HMDD), and 6 belongs to
tissue specificity category (TissueSpecific) (Figure 2).
These miRNA categories include more than 400 distinct
miRNAs.
The procedure of TAM analysis
TAM works in four steps, as shown in Figure 3. In Step 1,
a given list of miRNA for analysis is entered. In Step 2,
another list of miRNA is entered as background. This step
is optional; if a background list is not provided, TAM will
use all miRNAs included in the miRNA database as the
default background list. In Step 3, the user indicates what
analysis (overrepresentation or underrepresentation) is to
be performed: overrepresentation or underrepresentation.
In Step 4, a result page is generated after the data is sub-
mitted. TAM evaluates the significance of each miRNA
category for the given miRNAs. The miRNA categories
are clustered into five classes including miRNA family,
miRNA cluster, miRNA function, miRNA associated dis-
ease, and miRNA tissue specificity (Table 1). In the result
page, the miRNA category, number of input miRNAs
matched this category, percentage of matched miRNAs,
fold of the overpresentation or underrepresentation,
p value, Bonferroni value, and FDR value are listed, respec-
tively. Other related miRNAs with the given miRNAs in
one miRNA category will be shown when the mouse
move to corresponding miRNA category.
The upregulated and downregulated miRNAs in acute
myocardial infarction (AMI) show different TAM
annotations
We first applied TAM to the 16 deregulated miRNA genes
from a miRNA microarray experiment (Table 2), in which
we previously identified 16 deregulated miRNAs (8 are
upregulated in AMI and 8 are downregulated in AMI) in
the myocardium tissue of rats with AMI and normal rats
[16]. This dataset includes miRNA expression profiles
across four time points (the control, 3 day, 7 day, and
14 day), each time point has three samples and each sam-
ple has two replicates. In order to investigate the meaning-
ful rules behind these deregulated miRNAs, we identified
the enriched miRNA categories for the upregulated miR-
NAs and downregulated miRNAs, respectively. As a result,
the upregulated miRNAs and downregulated miRNAs
show obviously different and even opposite enriched
miRNA categories. Figure 4 shows the fold of enrichment
for the most enriched miRNA categories (P < 0.01). Signif-
icantly, the upregulated miRNAs are enriched in miR-199a
cluster (P = 1.49 × 10
-4), whereas the downregulated miR-
NAs are enriched in miR-181c cluster (P = 2.71 × 10
-3).
For the miRNA family, the upregulated miRNAs and
downregulated miRNAs are enriched in miR-17 family
(P = 4.03 × 10
-3) and miR-181 family (P = 1.64 × 10
-3),
respectively. For the miRNA function, the two lists of
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NAs are enriched in oncogenic function (P = 2.56 × 10
-4)
and immune system function (P = 1.01 × 10
-3), whereas
the downregulated miRNAs are enriched in tumor sup-
pressor function (P = 1.36 × 10
-4). Consequently, both lists
of miRNAs are enriched in tumors (Table 2). In addition,
the upregulated miRNAs are enriched in hypertrophic
cardiomyopathy and atrophic muscular disorders, whereas
the downregulated miRNAs are enriched in cardiac
arrhythmias, cardiomegaly, coronary artery disease, and
polycythemia vera (Table 2). In function, the upregulated
miRNAs are also enriched in Akt pathway, cell cycle, HIV
latency, hormones regulation, stem cell regulation,
immune, and inflammation; the downregulated miRNAs
are also enriched in cardiogenesis, hormones regulation,
and muscle development. Finally, although not so signifi-
cant, the downregulated miRNAs tend to be enriched in
function of muscle development (P = 0.01) and tend to be
heart and muscle specific (P = 0.15). The enriched miRNA
categories of AMI upregulated and downregulated miR-
NAs might provide help in understanding AMI. For exam-
ple, the upregulated miRNAs are enriched in function of
oncogenes, whereas the downregulated miRNAs are
enriched in function of tumor suppressors. This result
suggests that the deregulated miRNAs tend to stimulate
the proliferation of cardiac fibroblasts, which is further
helpful for collagen synthesis and cardiac remodeling. This
may be a compensatory mechanism for acutely infracted
myocardium.
To valid our method, we applied TAM to the deregu-
lated miRNAs of AMI from another independent miRNA
expression profiling experiment of AMI rat model by
Rooij et al.[17]. In their study, Rooij et al. identified 39
upregulated miRNAs and 46 downregulated miRNAs,
respectively. As a result, although the deregulated
Figure 1 Classification schemes of miRNA categories. We integrated miRNAs into various categories according to five classification schemes.
They are miRNA family, miRNA cluster, miRNA associated disease, miRNA function, and miRNA tissue specificity. The data sources used to
generate the above miRNA categories are also given.
Figure 2 The distribution of the five types of miRNA
categories. The size of the pie indicates the relative number of
miRNA categories in each classification.
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e n tf r o mt h o s eo fS h ie ta l . ’, the enriched miRNA cate-
gories identified by TAM have a good consistency across
these two independent experiments. For example, the
upregulated miRNAs from Rooij et al.’ experiment are
also enriched in miR-199a cluster (P = 4.33 × 10
-3), miR-
199 family (P = 4.33 × 10
-3), cell cycle (P = 6.37 × 10
-3),
stem cell regulation (P = 1.82 × 10
-6), inflammation
(P = 3.14 × 10
-3), and onco-miRNAs (P = 5.73 × 10
-5).
For HMDD category, the upregulated miRNAs are also
enriched in various cancer, hypertrophic cardiomyopathy
(P = 0.04) and atrophic muscular disorders (P = 4.54 ×
10
-12); the downregulated miRNAs from Rooij et al.’
experiment are also enriched in miR-29a cluster
(P = 7.37 × 10
-3), miR-29b cluster (P = 7.37 × 10
-3), hor-
mones regulation (P = 2.14 × 10
-7), miRNA tumor sup-
pressor (P = 9.23 × 10
-3). For HMDD category, the
downregulated miRNAs are also enriched in various can-
cer, and polycythemia vera (P = 7.01 × 10
-3).
Prediction of novel miRNAs related to AMI
As discussed previously, one of the limitations of target-
based pathway enrichment analysis of miRNAs is that it
can not predict novel miRNAs related to the inputted
miRNAs. For TAM, it is very easy to perform this kind
of analysis because TAM integrated miRNAs directly
but not integrated miRNAs through miRNA targets. In
the enriched miRNA category, the other miRNAs that
are not included in the input miRNA list could be
potential novel miRNAs related to the inputted miR-
NAs. For example, TAM analysis showed that the 16
deregulated miRNAs in AMI from Shi et al.’ss t u d y
are enriched in the function of muscle development
(P = 0.04). Among the 11 miRNAs in this category, two
(miR-1 and miR-499) are included in the 16 inputted
miRNAs. The other 9 miRNAs (miR-24, miR-124, miR-
133a, miR-23a, miR-133b, miR-206, miR-221, miR-222,
and miR-208b) in this category are predicted to be
potential novel AMI related miRNAs. We confirmed
four (miR-24, miR-133a, miR-221, and miR-222) of the
n i n em i R N A s( 4 4 . 4 % )a r er e l a t e dt oA M Ib a s e do nt h e
deregulated miRNAs from another independent study
by Rooij et al.[17]. The results indicate that TAM is a
highly reliable tool for predicting novel miRNAs that are
related to inputted miRNAs.
Discussion
As the rapid development of high-throughput biological
techniques, it is increasingly important to mine meaning-
ful patterns for a given list of miRNAs. As described
above, TAM represents one important tool for this pur-
pose. Unlike tools based on in-silico predicted miRNA tar-
gets, TAM integrated miRNAs into groups directly based
on miRNA annotations. Therefore, TAM represents a new
Figure 3 Analysis flowchart of TAM.
Table 1 Options provided by the TAM tool
Annotation Description
miRNA family miRNA categories integrated according to miRNA conservation
miRNA cluster miRNA categories integrated according to miRNA genome location
miRNA function miRNA categories integrated according to their function
miRNA associated disease miRNA categories integrated according to the associated disease
miRNA tissue specificity miRNA categories integrated according to their tissue specificity
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alternative tool for the annotations of a given list of miR-
NAs. Furthermore, TAM is able to predict novel miRNAs
that are related to the inputted miRNAs. This enables
users to find novel miRNA biomarkers for their experi-
ments. In addition, TAM is highly dependent on the data
of integrated miRNA sets and will be improved greatly
when more miRNA annotation data becomes available in
the future.
Conclusions
In this study, we presented a method to identify overre-
presented and/or underrepresented miRNA categories
for a given list of miRNAs. Moreover, an online tool,
TAM, for annotations of human miRNAs based on var-
ious miRNA sets is developed. After applying TAM to
deregulated miRNAs in AMI, we show that the upregu-
lated miRNAs and the downregulated miRNAs in AMI
are enriched in different and even opposite miRNA
categories, which is helpful for the understanding of
AMI. In addition, TAM can be used to predict novel
miRNAs that are mostly related to the input miRNAs.
TAM is useful for providing potential clues for miRNAs
of interest. Furthermore, TAM is scalable and will grow
and improve as more miRNA resources become avail-
able. In addition, TAM can be easily reconfigured for
use with other species.
Methods
miRNA sets
miRNA sets are defined as groups of miRNAs that have
meaningful relationships. If any two miRNAs have
meaningful relationships, for example they are asso-
ciated with the same diseases, they are then integrated
into one miRNA set. Here, miRNA sets were collected
according to miRNA family, genome locations, function,
associated diseases, and tissue specificity. Studies have
indicated that miRNAs in one family are most likely
derived from duplications of common ancestor miRNAs
[18,19], and tend to act together in various functional
processes [20,21]. Therefore, miRNAs in one family can
be considered as one miRNA set. The miRNA family
data from the miRBase database was downloaded [7]
and utilized in this study.
miRNAs are not located randomly in the genome but
tend to exist in clusters [22]. MiRNAs in a cluster are
likely to be co-transcribed and have similar expression
patterns [23]. Therefore, these clustered miRNAs may
be involved in similar biological processes. In this study,
miRNA clusters were identified by grouping miRNAs
that were within a distance of 50 kb in the chromo-
somes, according to the observation of Baskerville and
Bartel [23]. The integrated miRNAs were also manually
Table 2 Significant miRNA categories of upregulated and downregulated miRNAs in AMI obtained by TAM
miRNA
category
Upregulated miRNAs Downregulated miRNAs
(miR-31; miR-18a;miR-18b; miR-214;miR-223;miR-923; miR-711;miR-199a) (miR-499;miR-29b;miR-126; miR-1;miR-181d;miR-181c;
miR-451;miR-26b)
Family miR-17;miR-199 miR-181;miR-26
Cluster miR-199a miR-1;miR-144;miR-181c; miR-29a;miR-29b
Function Akt pathway;cell cycle; HIV latency;Hormones regulation; stem cell
regulation;immune; inflammation;oncogenic
Cardiogenesis; Hormones regulation; tumor suppressor;
Muscle development
HMDD Cancer; hypertrophic cardiomyopathy; atrophic muscular disorders; Cancer; Cardiac Arrhythmias; Cardiomegaly; Coronary
Artery Disease; polycythemia vera;
Tissue
Specific
Not available Not available
Figure 4 Enriched miRNA categories for the upregulated
miRNAs (A) and the downregulated miRNAs (B) in acute
myocardial infarction. Red, orange, yellow, and green colors
represent that the corresponding miRNA category is miRNA family,
miRNA cluster, miRNA function, and HMDD miRNA associated
disease, respectively.
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tions, as reported in publications. For example, miRNAs
that were associated with the immune system were col-
lected from a recent review paper published in Cell [24].
The miRNA sets were generated by miRNA-associated
diseases based on the Human MicroRNA Disease
Database (HMDD, http://cmbi.bjmu.edu.cn/hmdd), a
database for miRNA disease associations [3]. The tissue-
specific index values of miRNA were obtained from the
study of Lu et al.[3], and tissue-specific miRNA sets
were generated by collecting miRNAs with tissue speci-
ficity index values of greater than or equal to 0.7.
Finally, according to the methods described above, 257
miRNA sets were generated. These miRNA sets are
available for download at the TAM website.
Evaluation of statistical significance
The hypergeometric test [25], was used to determine the
significant overrepresentation and/or underrepresenta-
tion of the miRNA sets among a list of miRNAs of
interest. Assuming that P represents the number of
miRNAs included in all miRNA sets, S represents the
number of miRNAs included in miRNA set A, HP
represents the number of input miRNAs included in P,
and HS represents the number of miRNAs that are of
interest included in S, the probability of HS miRNAs of










where the symbol “C” means the combination opera-
tion. Therefore, the statistical significance of miRNA set
A among the miRNAs of interest are represented by
Formula (2) and (3):
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Finally, the P values for all miRNA sets are adjusted
by Bonferroni and FDR corrections.
Availability and requirements
Project name: TAM.
Project home page: http://cmbi.bjmu.edu.cn/tam.
Operating system: Platform independent.
Programming language: Python.
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